NO318553B1 - Anvendelse av 2-metyl-4-(4-metyl-1-piperazinyl)-10H-tieno[2,3-b][1,5]benzodiazepin for behandling av en kognitiv dysfunksjon. - Google Patents

Anvendelse av 2-metyl-4-(4-metyl-1-piperazinyl)-10H-tieno[2,3-b][1,5]benzodiazepin for behandling av en kognitiv dysfunksjon. Download PDF

Info

Publication number
NO318553B1
NO318553B1 NO19974766A NO974766A NO318553B1 NO 318553 B1 NO318553 B1 NO 318553B1 NO 19974766 A NO19974766 A NO 19974766A NO 974766 A NO974766 A NO 974766A NO 318553 B1 NO318553 B1 NO 318553B1
Authority
NO
Norway
Prior art keywords
methyl
thieno
benzodiazepine
piperazinyl
cognitive dysfunction
Prior art date
Application number
NO19974766A
Other languages
English (en)
Norwegian (no)
Other versions
NO974766D0 (no
NO974766L (no
Inventor
Jr Charles M Beasley
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA002219902A priority Critical patent/CA2219902A1/en
Priority claimed from CA002219902A external-priority patent/CA2219902A1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to NO19974766A priority patent/NO318553B1/no
Publication of NO974766D0 publication Critical patent/NO974766D0/no
Publication of NO974766L publication Critical patent/NO974766L/no
Publication of NO318553B1 publication Critical patent/NO318553B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Processing Of Meat And Fish (AREA)
  • Light Receiving Elements (AREA)
NO19974766A 1995-05-30 1997-10-15 Anvendelse av 2-metyl-4-(4-metyl-1-piperazinyl)-10H-tieno[2,3-b][1,5]benzodiazepin for behandling av en kognitiv dysfunksjon. NO318553B1 (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002219902A CA2219902A1 (en) 1995-05-30 1995-05-30 Use of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno¬2,3b|¬1,5|benzodiazepine for treating cognitive dysfunction
NO19974766A NO318553B1 (no) 1995-05-30 1997-10-15 Anvendelse av 2-metyl-4-(4-metyl-1-piperazinyl)-10H-tieno[2,3-b][1,5]benzodiazepin for behandling av en kognitiv dysfunksjon.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002219902A CA2219902A1 (en) 1995-05-30 1995-05-30 Use of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno¬2,3b|¬1,5|benzodiazepine for treating cognitive dysfunction
PCT/US1995/006859 WO1996038151A1 (en) 1995-05-30 1995-05-30 Method for treating cognitive dysfunction
NO19974766A NO318553B1 (no) 1995-05-30 1997-10-15 Anvendelse av 2-metyl-4-(4-metyl-1-piperazinyl)-10H-tieno[2,3-b][1,5]benzodiazepin for behandling av en kognitiv dysfunksjon.

Publications (3)

Publication Number Publication Date
NO974766D0 NO974766D0 (no) 1997-10-15
NO974766L NO974766L (no) 1997-12-09
NO318553B1 true NO318553B1 (no) 2005-04-11

Family

ID=25679786

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974766A NO318553B1 (no) 1995-05-30 1997-10-15 Anvendelse av 2-metyl-4-(4-metyl-1-piperazinyl)-10H-tieno[2,3-b][1,5]benzodiazepin for behandling av en kognitiv dysfunksjon.

Country Status (16)

Country Link
EP (1) EP0828494B1 (cs)
JP (1) JPH11506096A (cs)
AT (1) ATE220550T1 (cs)
AU (1) AU707858B2 (cs)
CZ (1) CZ292565B6 (cs)
DE (1) DE69527442T2 (cs)
DK (1) DK0828494T3 (cs)
ES (1) ES2180643T3 (cs)
FI (1) FI973987A0 (cs)
HU (1) HUT77907A (cs)
MX (1) MX9707936A (cs)
NO (1) NO318553B1 (cs)
NZ (1) NZ288037A (cs)
PL (1) PL189714B1 (cs)
PT (1) PT828494E (cs)
WO (1) WO1996038151A1 (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
UA57727C2 (uk) * 1996-03-11 2003-07-15 Елі Ліллі Енд Компані Спосіб лікування надмірної агресивності
PL196814B1 (pl) 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
EP1709053B1 (en) 2004-01-27 2011-04-06 Synthon B.V. Stable salts of olanzapine
PT1838716E (pt) 2005-01-05 2011-07-15 Lilly Co Eli Di-hidrato de pamoato de olanzapina
PL381564A1 (pl) 2007-01-22 2008-08-04 Koźluk Tomasz Nobilus Ent Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270464A (en) * 1989-03-14 1993-12-14 Janssen Pharmaceutica N.V. Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
NZ288037A (en) 1999-09-29
CZ292565B6 (cs) 2003-10-15
MX9707936A (es) 1997-12-31
EP0828494A4 (en) 1999-11-24
NO974766D0 (no) 1997-10-15
WO1996038151A1 (en) 1996-12-05
FI973987A7 (fi) 1997-10-17
EP0828494B1 (en) 2002-07-17
FI973987L (fi) 1997-10-17
CZ324397A3 (cs) 1998-08-12
EP0828494A1 (en) 1998-03-18
PT828494E (pt) 2002-10-31
ATE220550T1 (de) 2002-08-15
HUT77907A (hu) 1998-10-28
JPH11506096A (ja) 1999-06-02
DE69527442T2 (de) 2003-02-20
ES2180643T3 (es) 2003-02-16
NO974766L (no) 1997-12-09
PL189714B1 (pl) 2005-09-30
FI973987A0 (fi) 1997-10-17
AU2693695A (en) 1996-12-18
HK1009393A1 (en) 1999-06-04
AU707858B2 (en) 1999-07-22
PL323785A1 (en) 1998-04-27
DE69527442D1 (de) 2002-08-22
DK0828494T3 (da) 2002-09-02

Similar Documents

Publication Publication Date Title
AU706471B2 (en) Process and crystal forms of 2-methyl-thieno-benzodiazepine
AU720366B2 (en) Olanzapine dihydrate D
HUP0001508A2 (hu) 4-(Aril-metil)-2-imino-2,3-dihidro-tiazol-származékok, alkalmazásuk, az előállításukra szolgáló eljárás és az ezeket tartalmazó gyógyszerkészítmények
US5776928A (en) Method for treating dyskinesias with olanzapine
AU2007327585B2 (en) Polymorphic forms of deferasirox ( ICL670A)
NO318553B1 (no) Anvendelse av 2-metyl-4-(4-metyl-1-piperazinyl)-10H-tieno[2,3-b][1,5]benzodiazepin for behandling av en kognitiv dysfunksjon.
US5696115A (en) Method for treating nicotine withdrawal
RU2002752C1 (ru) Способ получени бензодиазепиновых соединений
KR100366895B1 (ko) 인식기능장해치료용제약조성물
US6506746B2 (en) Method for treating cognitive dysfunction
JPH08325151A (ja) 食欲不振を治療する方法
RU2176914C2 (ru) Способ лечения нарушения познавательной функции
JP2000517287A (ja) 物質乱用の処置方法
CA2219902A1 (en) Use of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno¬2,3b|¬1,5|benzodiazepine for treating cognitive dysfunction
HK1009393B (en) Method for treating cognitive dysfunction
NZ325035A (en) Method for treating excessive aggression using olanzapine
HK1013988B (en) Crystal forms of a thieno(2,3-b)(1,5) benzodiazepine derivative and process for their preparation